Annual Drug Patent Expirations for KYNMOBI
Kynmobi is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from one supplier. There are eighteen patents protecting this drug.
Drug patent litigation for KYNMOBI.
This drug has two hundred and thirty-four patent family members in twenty-four countries.
The generic ingredient in KYNMOBI is apomorphine hydrochloride. One supplier is listed for this compound. Additional details are available on the apomorphine hydrochloride profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
